Read + Share
Korompoki E, Douketis JD. In patients with ESUS, the effects of OAC and antiplatelet therapy on recurrent
ischemic stroke differ across subgroups at 1 to 5 y. Ann Intern Med 2025 Feb 4. doi: 10.7326/ANNALS-24-03608.
PMID: 39899864
|
 |
|
Korompoki E, Douketis JD. In patients with ESUS, the effects of OAC and antiplatelet therapy on recurrent
ischemic stroke differ across subgroups at 1 to 5 y. Ann Intern Med 2025 Feb 4. doi: 10.7326/ANNALS-24-03608.
PMID: 39899864
|
|
|
|